Search
for
Sort by
Research 421–450 of 739
- Update on Hidradenitis Suppurativa (Part I): Epidemiology, Pathogenesis, Severity assessment and Comorbidities
- Androgenisierung
- Unveiling the power of individualized homoeopathic medicine in the treatment of alopecia areata: A case series
- Alopecia areata
- Dermatological Manifestations of COVID-19: A Brief Review
- Cutaneous lupus erythematosus. Diagnostic and therapeutic recommendations of the Polish Dermatological Society
- Australasian Society for Dermatology Research Meeting, May 2006
- Topische Immuntherapie mit Diphenylcyclopropenon bei verschiedenen Typen der Alpecia areata: Assoziation zu klinischen Parametern und einem funktionellen Genpolymorphismus des Interleukin-6-Promotors
- Correspondence
- Alopecia areata secondary to the use of leflunomide in patients with rheumatoid arthritis: a case report and literature review
- Dermatología en la Práctica Médica General Vol. 13
- Alopecia areata, actualización clínica y terapéutica
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- AVALIAÇÃO DA CRIPTOSPORIDIOSE EM CÃES E SUAS IMPLICAÇÕES NA SAÚDE ÚNICA
- Farmácia Militar do Laboratório Nacional do Medicamento, Porto e Serviços Farmacêuticos do Centro Hospitalar Universitário do Porto (Hospital de Santo António), EPE, Porto
- Uso de corticoides no tratamento da Alopecia Areata
- LÍQUEN PLANO PILAR – RELATO DE UM CASO ASSOCIADO A DOENÇAS AUTOIMUNES
- Scent of telogen effluvium
- Trimethoprim-Induced Aseptic Meningitis
- Treatment of Satoyoshi syndrome: a systematic review
- An Update on the Roles of the Complement System in Autoimmune Diseases and the Therapeutic Possibilities of Anti-Complement Agents
- Aplasia cutis congenita on lumbosacral area
- Clinical Case of Tofacitinib Therapy in Autoimmune Alopecia in Patient with Ulcerative Colitis
- A Pilot Randomized Controlled Trial Comparing the Efficacy and Safety of Oral Tofacitinib Versus Methotrexate In Moderate-to-Severe Alopecia Areata
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- Cronkhite–Canada Syndrome With Multiple Mesenteric Lymphadenopathy: A Case Report
- Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise
- Efficacy and Safety of Baricitinib in Patients With Alopecia Areata: A Real‐World Cohort Study
- Efficacy of mesalazine in children with moderate to severe alopecia areata: case series of 18 patients
- WARFARIN